Abstract:ABSTRACT Heteroresistance refers to phenotypic heterogeneity of microbial clonal populations under antibiotic stress, and it has been thought to be an allocation of a subset of “resistant” cells for surviving in higher concentrations of antibiotic. The assumption fits the so-called bet-hedging strategy, where a bacterial population “hedges” its “bet” on different phenotypes to be selected by unpredicted environment stresses. To test this hypothesis, we constructed a heteroresistance model by introducing a blaCTX-M-14 gene (coding for a cephalosporin hydrolase) into a sensitive Escherichia coli strain. We confirmed heteroresistance in this clone and that a subset of the cells expressed more hydrolase and formed more colonies in the presence of ceftriaxone (exhibited stronger “resistance”). However, subsequent single-cell-level investigation by using a microfluidic device showed that a subset of cells with a distinguishable phenotype of slowed growth and intensified hydrolase expression emerged, and they were not positively selected but increased their proportion in the population with ascending antibiotic concentrations. Therefore, heteroresistance—the gradually decreased colony-forming capability in the presence of antibiotic—was a result of a decreased growth rate rather than of selection for resistant cells. Using a mock strain without the resistance gene, we further demonstrated the existence of two nested growth-centric feedback loops that control the expression of the hydrolase and maximize population growth in various antibiotic concentrations. In conclusion, phenotypic heterogeneity is a population-based strategy beneficial for bacterial survival and propagation through task allocation and interphenotypic collaboration, and the growth rate provides a critical control for the expression of stress-related genes and an essential mechanism in responding to environmental stresses. IMPORTANCE Heteroresistance is essentially phenotypic heterogeneity, where a population-based strategy is thought to be at work, being assumed to be variable cell-to-cell resistance to be selected under antibiotic stress. Exact mechanisms of heteroresistance and its roles in adaptation to antibiotic stress have yet to be fully understood at the molecular and single-cell levels. In our study, we have not been able to detect any apparent subset of “resistant” cells selected by antibiotics; on the contrary, cell populations differentiate into phenotypic subsets with variable growth statuses and hydrolase expression. The growth rate appears to be sensitive to stress intensity and plays a key role in controlling hydrolase expression at both the bulk population and single-cell levels. We have shown here, for the first time, that phenotypic heterogeneity can be beneficial to a growing bacterial population through task allocation and interphenotypic collaboration other than partitioning cells into different categories of selective advantage.

Phenotypic heterogeneity in bacteria: the rise of antibiotic persistence, clinical implications, and therapeutic opportunities

Antibiotic resistance and persistence—Implications for human health and treatment perspectives

Link Between Antibiotic Persistence and Antibiotic Resistance in Bacterial Pathogens

Decoding Bacterial Persistence: Mechanisms and Strategies for Effective Eradication

Unlocking the enigma of phenotypic drug tolerance: Mechanisms and emerging therapeutic strategies

Antibiotic Tolerance Indicative of Persistence Is Pervasive among Clinical Streptococcus pneumoniae Isolates and Shows Strong Condition Dependence

Molecular mechanisms of bacterial persistence and phenotypic antibiotic resistance.

Environmental, mechanistic and evolutionary landscape of antibiotic persistence

A paradox of bacterial persistence and antibiotic resistance: chloramphenicol acetyl transferase as a double barrel shot gun

Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence

Antibiotic dose and nutrient availability differentially drive the evolution of antibiotic resistance and persistence

Antibiotic Persistence as a Metabolic Adaptation: Stress, Metabolism, the Host, and New Directions

Antibiotic resistant bacteria survive treatment by doubling while shrinking

Emergent antibiotic persistence in a spatially structured synthetic microbial mutualism

Heteroresistance at the Single-Cell Level: Adapting to Antibiotic Stress Through a Population-Based Strategy and Growth-Controlled Interphenotypic Coordination

Phenotypic resistant single-cell characteristics under recurring ampicillin antibiotic exposure in Escherichia coli

The Evolution of Heteroresistance via Small Colony Variants in Escherichia coli Following Long Term Exposure to Bacteriostatic Antibiotics

Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update

Molecular mechanism and application of emerging technologies in study of bacterial persisters

Ecological and evolutionary mechanisms driving within-patient emergence of antimicrobial resistance

Definitions and guidelines for research on antibiotic persistence